Purchase Order 1232SD18P0474
- Not listed
- The U.S. government awarded a $3,194.98 firm fixed-price purchase order to Genscript USA Inc. on May 5, 2015, for custom gene synthesis services. The contract, with an ultimate completion date of September 30, 2015, was funded by a civilian agency within the Midwest Area and performed at the contractor's facility in Piscataway, New Jersey. No set-aside designation was applied to this award. Genscript USA Inc., a biotechnology company specializing in advanced molecular biology services, has...
- The U.S. government awarded a $3,681.17 firm fixed-price purchase order to Genscript USA Inc. for protein synthesis services on April 8, 2019, with a completion date of May 31, 2019. The contract was issued by a civilian federal agency within the Pacific West Area and will be performed at Genscript's headquarters in Piscataway, New Jersey. No set-aside designation was applied to this award, making it available to all qualified vendors in full and open competition. Genscript USA Inc., a...
- This firm fixed-price purchase order, valued at $14,607.70, was awarded by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc. for gene synthesis and cloning services. The ultimate completion date is August 29, 2024. Genscript is a biotechnology company based in Piscataway, New Jersey that specializes in molecular biology products and services to support biomedical research and public health initiatives for various federal agencies, including the National...
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $3,943.72 contract is for custom gene synthesis services to support NIAID's biomedical research programs. Genscript, a for-profit organization, has a strong track record of providing specialized molecular biology products and services to...
- This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
- This federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, is for the provision of a wide range of molecular biology products and services to support biomedical research and public health initiatives. The $19,395.39 firm fixed-price purchase order contract, awarded by the National Institute of Child Health and Human Development (NICHD), covers gene synthesis, cloning, protein expression and purification, antibody production, and other...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, for custom gene synthesis services. The contract has a potential value of $21,275.80 and a completion date of August 19, 2020. Genscript, based in Piscataway, New Jersey, specializes in gene synthesis, gene editing, custom protein and...
- This $4,448.22 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for custom protein and DNA synthesis services to support biomedical research and public health initiatives. Genscript specializes in providing a range of molecular biology products and services, including gene...
- This federal contract award, valued at $88,327.43, was issued by the U.S. Department of Agriculture (USDA) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, which is a firm fixed-price purchase order, is for the provision of DNA fragments with 100% guaranteed sequence to support the USDA's Agricultural Research Service (ARS) Plains Area. This award is set aside for small businesses and was made under a solicitation that had a North American Industry...
- This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $20,092.74 firm fixed price contract is for custom gene synthesis services. The contract has no set-aside designation. Genscript specializes in gene synthesis, gene editing, and other molecular biology services, and has received...
The U.S. government awarded a $2,656 firm fixed-price purchase order to Genscript USA Inc. for molecular biology services on July 28, 2018, with an ultimate completion date of August 15, 2018. The contract, issued by the Pacific West Area civilian agency, calls for the synthesis of a CAMV 35S promoter followed by a CTV-RB115 sequence consisting of 5,711 base pairs and the cloning of this sequence in pBluescript II SK(+) vector. The work will be performed at Genscript's facility in Piscataway, New Jersey. This award does not utilize a set-aside designation. Genscript USA Inc., a biotechnology company specializing in advanced molecular biology services, is well-positioned to deliver these gene synthesis and cloning services. The company has a robust track record supporting federal research institutions, including the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, and the Department of Agriculture, with contract values ranging from approximately $10,000 to over $3 million. The company's expertise in custom gene synthesis, plasmid preparation, and specialized research support for life sciences applications makes it a critical vendor for federal biomedical research initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/10/18 |